Thank you for sharing!

Your article was successfully shared with the contacts you provided.

CAMBRIDGE, MA-This city’s market is getting a boost from biotech firms who are filling vacant lab space. The leases have dropped the city’s laboratory vacancy rate by 7% during the third quarter, a market report by Cresa Partners shows.

While lab vacancy rates still remain high at 15%, users of 50,000 sf or more are finding the market for vacant laboratories in this city’s biotech corridor rapidly tightening. Adam Subber, a vice president with Cresa, tells GlobeSt.com that the 7% drop in lab vacancy rates is due mainly to a number of large users, including Vertix, which recently announced that it will take three floors at Cambridge’s 675 W. Kendall St. Pharmaceutical giant Sanofi Aventis is reportedly looking for 60,000 sf to 70,000 sf for an expanded research site and CombintoRx, which is relocating from Boston, will expand its 245 First St. operation by more than 40,000 SF.

Altus Pharmaceuticals and Shearing Plough are also looking to expand significantly, Subber says. “Earlier this year, there were about half a dozen options available for biotech companies seeking 50,000 to 70,000 sf,” Dan Sullivan, also a vice with Cresa, says. “Now, there are only two or three viable options.”

The tightening market has also driven up asking rates for lab space from last quarter’s $38 to $45 per sf to $40 to $55 per sf in the current quarter, Cresa found. The strengthening of Cambridge’s biotech market may also fuel speculative development of lab space in the area, says Subber. Lyme Properties has already said it will proceed with the first phase of its 301 Binney St. project. That will ultimately add 450,000 sf of laboratory space to the market in the area’s first speculative development in three years.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?

Dig Deeper


Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.